InfraReDx Inc. of Burlington said Wednesday that it has received CE mark approval in Europe to start commercializing its LipiScan IVUS Coronary Imaging System.

The company received 510(k) medical device clearance from the U.S. Food and Drug Administration for the product in 2010.

SOURCE